Skip to main content
. 2017 Mar 16;3:105–115. doi: 10.1016/j.pvr.2017.03.002

Table 7.

Month 7 anti-HPV geometric mean titers in women, 16–26 years of age who completed the 3-dose 9vHPV vaccine regimen in study 001.

Per protocol immunogenicity population
Day 1 seropositive and PCR-negative
Assay
time point
n GMT (95% CI) n GMT (95% CI)
HPV 6
Day 1 3993 <16 (<16, <16) 917 108.1 (102.2, 114.3)
Month 3 788 734.0 (692.8, 777.7) 188 2384.0 (1982.9, 2866.1)
Month 7 3993 893.1 (871.7, 915.1) 752 1874.8 (1737.6, 2022.8)
Month 12 800 330.6 (312.2, 350.1) 213 951.9 (807.3, 1122.3)
Month 24 715 208.6 (195.5, 222.7) 182 634.3 (529.6, 759.8)
Month 36 685 163.9 (153.0, 175.6) 155 462.9 (382.5, 560.2)
Month 42 692 147.2 (137.3, 157.8) 163 444.1 (369.2, 534.3)
HPV 11
Day 1 3995 <6 (<6, <6) 208 44.6 (39.2, 50.8)
Month 3 790 529.1 (499.7, 560.1) 44 1666.4 (1229.9, 2257.9)
Month 7 3995 666.3 (649.6, 683.4) 175 1050.2 (914.9, 1205.6)
Month 12 810 212.4 (200.1, 225.6) 49 609.9 (465.7, 798.9)
Month 24 763 123.3 (115.8, 131.2) 40 360.7 (264.9, 491.0)
Month 36 690 89.6 (83.3, 96.3) 35 214.4 (149.4, 307.7)
Month 42 696 84.9 (79.0, 91.3) 34 201.9, (140.6, 289.8)
HPV 16
Day 1 4032 <12 (<12, <12) 564 126.6 (115.1, 139.3)
Month 3 794 2435.8 (2303.5, 2575.6) 104 7064.1 (5775.9, 8639.7)
Month 7 4032 3131.1 (3057.1, 3206.9) 458 5149.6 (4752.9, 5579.5)
Month 12 819 1041.7 (979.9, 1107.4) 134 3079.9 (2582.1, 3673.6)
Month 24 778 520.7 (484.7, 559.4) 98 1824.4 (1436.6, 2316.9)
Month 36 695 386.5 (356.3, 419.4) 82 1228.6 (939.5, 1606.6)
Month 42 709 346.8 (319.3, 376.7) 90 1186.7 (934.8, 1506.4)
HPV 18
Day 1 4539 <8 (<8, <8) 296 83.0 (74.3, 92.8)
Month 3 908 470.8 (442.8, 500.7) 58 1920.1 (1464.2, 2517.9)
Month 7 4539 804.6 (782.7, 827.1) 241 1883.4 (1670.6, 2123.4)
Month 12 929 198.6 (184.9, 213.4) 72 1012.7 (773.7, 1325.6)
Month 24 886 86.0 (79.0, 93.6) 52 537.2 (390.1, 739.8)
Month 36 789 78.5 (71.9, 85.6) 48 397.0 (285.8, 551.5)
Month 42 806 70.8 (64.8, 77.3) 47 374.9 (268.6, 523.2)
HPV 31
Day 1 4466 <4 (<4, <4) 373 38.7 (35.0, 42.6)
Month 3 881 437.6 (406.7, 470.8) 83 825.6 (609.4, 1118.4)
Month 7 4466 658.4 (636.7, 680.9) 295 952.8 (831.5, 1091.8)
Month 12 909 196.5 (183.5, 210.4) 90 452.2 (340.3, 600.8)
Month 24 863 101.9 (94.9, 109.5) 71 242.0 (174.5, 335.6)
Month 36 772 72.7 (67.5, 78.4) 62 182.1 (128.4, 258.4)
Month 42 783 70.4 (65.3, 75.9) 68 163.7 (119.9, 223.4)
HPV 33
Day 1 4702 <4 (<4, <4) 248 24.9 (22.1, 28.0)
Month 3 937 287.8 (272.9, 303.5) 50 647.0 (459.2, 911.4)
Month 7 4702 415.9 (405.6, 426.4) 196 660.4 (550.1, 792.9)
Month 12 958 126.2 (119.9, 132.9) 68 372.9 (276.8, 502.4)
Month 24 909 65.3 (61.7, 69.0) 52 243.3 (169.1, 349.8)
Month 36 813 46.8 (44.0, 49.8) 45 184.0 (124.1, 272.9)
Month 42 835 44.3 (41.6, 47.1) 39 172.6 (111.8, 266.5)
HPV 45
Day 1 4792 <3 (<3, <3) 97 23.7 (20.2, 27.9)
Month 3 956 160.4 (151.7, 169.7) 14 389.1 (197.5, 766.4)
Month 7 4792 252.8 (246.2, 259.6) 76 346.8 (244.3, 492.4)
Month 12 976 69.2 (65.4, 73.3) 18 203.5 (105.3, 393.5)
Month 24 928 33.0 (31.0, 35.0) 13 115.5 (51.6, 258.2)
Month 36 835 22.9 (21.4, 24.4) 11 60.8 (23.7, 155.8)
Month 42 846 21.1 (19.8, 22.5) 13 87.7 (36.9, 208.3)
HPV 52
Day 1 4455 <3 (<3, <3) 244 22.3 (20.3, 24.6)
Month 3 895 241.3 (229.7, 253.4) 41 877.2 (543.0, 1417.0)
Month 7 4455 379.7 (371.6, 388.0) 199 534.7 (447.2, 639.3)
Month 12 916 118.9 (113.0, 125.0) 53 450.3 (320.3, 633.0)
Month 24 867 57.9 (54.7, 61.2) 40 265.6 (175.1, 402.8)
Month 36 777 47.9 (45.0, 50.9) 34 177.7 (120.2, 262.8)
Month 42 791 43.2 (40.6, 46.0) 33 178.0 (120.8, 262.3)
HPV 58
Day 1 4486 <4 (<4, <4) 419 21.7 (19.9, 23.8)
Month 3 884 281.1 (265.3, 297.7) 85 546.2 (436.4, 729.4)
Month 7 4486 482.5 (469.9, 495.3) 342 606.2 (539.3, 681.5)
Month 12 905 153.3 (145.5, 161.6) 108 273.4 (219.0, 341.2)
Month 24 852 80.3 (75.7, 85.3) 84 147.4 (114.8, 189.3)
Month 36 765 55.0 (51.4, 58.8) 79 101.3 (78.0, 131.6)
Month 42 784 52.0 (48.7, 55.6) 76 95.1 (73.6, 122.9)

n=number of subjects contributing to the analysis.

GMT, geometric mean titer (given in milli-Merck units per milliliter).

CI, confidence interval.